🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific → Stable 4 quarters analysed

Q2 2025

Confident Specific

Management repeatedly used 'record' (7+ times) for fundings, investment income, NII, and first-half metrics; provided precise dollar and percentage figures; acknowledged Q3 seasonal slowness but gave specific prepayment range ($200M–$250M) and reaffirmed full-year record expectations.

Q3 2025

Confident Specific

Management repeatedly used words like 'record', 'strong', 'disciplined', and provided specific figures (e.g., $846M originations, $504.6M fundings, 122% dividend coverage) to emphasise consistent outperformance and strategic prudence.

Q4 2025

Confident Specific

The CEO repeatedly uses 'record' for many metrics (record originations, fundings, net investment income, AUM), and provides specific numbers and percentages, e.g., 'net investment income of $87 million or $0.48 per share', 'core yield of 12.5%'. The language is assertive and positive, with no hedging.

Q1 2026 latest

Confident Specific

Management used definitive language like 'all-time records', 'strong credit performance', and '120% coverage' while providing specific numbers (e.g., $1.81B originations, $141.5M investment income, 0.9% rated 4/5 loans). They proactively addressed market volatility, AI disruption, and liquidity concerns with detailed explanations of their capital structure advantages.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis is strengthened after this call due to record originations and investment income, stable credit (0.9% rated 4/5 lowest since Q2 2022), strong liquidity, and intentional capital structure isolation from retail redemption risks. The increased prepayment guidance ($350M-$500M in Q2) signals portfolio quality and provides capital for redeployment at potentially better terms. However, the rapid AI disruption and market volatility remain key risks; management's emphasis on structure over spread and the proprietary nature of their underwriting changes leave some uncertainty. Watch next quarter for actual prepayment realization, credit migration of software loans, and whether the redeployment yields actually improve or PIK continues to decline as expected.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →

📊 MIXED Hercules Capital Q1 2026: Record originations $1.81B, total investment income $141.5M

Revenue & Profitability

Record total investment income of $141.5 million (up 18.4% year-over-year). Net investment income of $88.1 million ($0.48 per share), up 13.8% year-over-year. GAAP effective yield 12.8%, core yield 12.2%. GAAP leverage 115.4%. Net asset value per share $11.90, down 1.9% from Q4 2025. Return on equity was 16.9%. Total originations were a record $1.81 billion and gross fundings exceeded $706 million.

Outlook

Management expects a robust new business environment for 2026 despite continued market volatility from AI disruption and Middle East conflict. Q2 originations are expected to moderate and be more back-end weighted, while prepayments are guided to increase materially to $350-500 million. Core yield is expected to remain relatively flat in Q2. M&A exit activity is expected to accelerate, but with more uncertainty on valuations and timing.

Growth Drivers

Key growth drivers include expansion of the platform (managing $6.1B, up 21.8% year-over-year), record originations driven by venture capital investment activity ($267.2B in Q1 2026 per PitchBook-NVCA), and strong capital raising across the portfolio (21 companies raised $3.4B in Q1). The company sees continued opportunity in both life sciences and technology, with AI-related companies representing over 88% of venture deal value.

Balance Sheet & CapEx

Not discussed in this earnings call.

Margins

ROE for Q1 was 16.9%, ROAA was 8.1%. Operating expenses (net of RIA recharge) were $53.4 million, driven by higher compensation from record originations. Interest expense increased to $30.8 million due to business growth. Weighted average cost of debt remained stable at 5.1%. For Q2, SG&A is guided to $27.5-28.5 million with RIA expense allocation of ~$4.5 million. Core yield is expected to remain in the 12-12.5% range.

Key Risks

Key risks include continued market volatility from AI disruption and the Middle East conflict, potential slowdown in M&A exit activity due to pricing and valuation discovery, the impact of AI on portfolio company business models, and the potential for increased prepayment variability. Analysts also noted a disconnect between venture market perceptions and the actual performance of Hercules' portfolio.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-07-30

Record Q2 results included all-time highs in investment income and net investment income, with robust originations and strong portfolio credit quality. Liquidity and leverage improved, and the outlook remains positive with expectations for continued strong originations and normalized prepayments.

Q1 2026 Q1 2026 2026-05-05

Record Q1 originations and investment income were achieved amid market volatility, with strong credit quality, robust liquidity, and a balanced portfolio across life sciences and technology. Elevated prepayments from M&A are expected in Q2, supporting continued capital redeployment.

Q4 2025 Q4 2025 2026-02-12

Record 2025 results included all-time highs in originations, fundings, and investment income, with strong credit quality and robust liquidity. The platform is well positioned for 2026, expecting continued growth, disciplined underwriting, and ongoing supplemental shareholder distributions.

Q3 2025 Q3 2025 2025-10-30

Record Q3 results included $138.1 million in investment income and $88.6 million net investment income, with strong portfolio growth and robust liquidity. Credit quality remained high, and guidance for Q4 and 2026 remains positive, with continued confidence in dividend coverage.

Q2 2025 Q2 2025 2025-07-31

Record Q2 results included $709.1M in gross fundings, $137.5M in investment income, and $88.7M in net investment income, with strong liquidity and improved credit quality. Outlook remains bullish for the second half of 2025, despite a seasonally slow Q3.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.